🇺🇸 FDA

Drug profile · INN

respiratory syncytial virus vaccine (bivalent, recombinant)

ABRYSVO

J07BX05
Patents linked
0
News articles
0

Quick answer

respiratory syncytial virus vaccine (bivalent, recombinant) (ABRYSVO) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN respiratory syncytial virus vaccine (bivalent, recombinant)
Brand ABRYSVO
ATC code J07BX05

Frequently asked questions

What is respiratory syncytial virus vaccine (bivalent, recombinant)?

respiratory syncytial virus vaccine (bivalent, recombinant) (ABRYSVO) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for respiratory syncytial virus vaccine (bivalent, recombinant)?

ABRYSVO is a marketed brand name for respiratory syncytial virus vaccine (bivalent, recombinant). Check FDA Drugs@FDA for the current US label holder and prescribing information.